
HHS justifies decision to stop recommending Covid shots during pregnancy with studies supporting the shots' safety
The document, which HHS sent to lawmakers days before Secretary Robert F. Kennedy Jr. announced his plan to fire the panel that advises the CDC on immunizations, says that studies have shown that women who got the vaccine during pregnancy had higher rates of various complications. And it claims that 'a number of studies in pregnant women showed higher rates of fetal loss if vaccination was received before 20 weeks of pregnancy,' footnoting a research paper on vaccination during pregnancy.
But Dr. Maria P. Velez of McGill University, the lead author of one of the studies, told POLITICO in an email that 'the results of our manuscript were misinterpreted.'
The 2023 study shows a slightly higher rate of miscarriages among women who were immunized against Covid-19 during their pregnancies. But, Velez said, that after adjusting for 'variables that can confound a crude association,' like 'age, rurality, neighbourhood income quintile, immigration status, comorbidity' and other factors that could affect the outcome, Canadian researchers found 'no association between SARS-CoV-2 vaccination and an increased risk of miscarriage.'
Raw numbers don't account for significant differences among the groups being compared — such as underlying conditions and when during pregnancy the people were vaccinated, said Katelyn Jetelina, an epidemiologist who's consulted for the Centers for Disease Control and Prevention. Scientists, including the Canadian researchers, use statistical methods to adjust for those factors, she said, which is how they determined the vaccine wasn't associated with miscarriage.
In a statement, HHS spokesperson Andrew Nixon pointed to the raw study data, which showed a slightly higher rate of miscarriage in the first half of pregnancy for women who were vaccinated against Covid compared with those who weren't.
'The underlying data speaks for itself — and it raises legitimate safety concerns,' he said. 'HHS will not ignore that evidence or downplay early pregnancy loss.'
Nixon added that HHS and the CDC encourage people to talk to their providers 'about any personal medical decision.'
Vaccine researchers and obstetricians criticized the decision to remove the recommendation for pregnant women, and researchers cited in the HHS document largely dismissed any connection between Covid vaccination and miscarriages.
'Given that COVID-19 infection during pregnancy is associated with serious maternal and neonatal morbidity, the current study can inform healthcare providers, pregnant women and those considering a pregnancy about the safety of SARS-CoV-2 vaccination in relation to miscarriage risk,' Velez and her co-authors wrote in the study. That research was based on health-system data from Ontario, Canada, and aligned with similar population studies in the U.S., Scotland and Norway.
Similarly, HHS cited an April 2022 study in its document concerning mRNA vaccination in people undergoing in-vitro fertilization, which also found no adverse effects on conception rates or on early pregnancy outcomes.
'Administration of COVID-19 mRNA vaccines was not associated with an adverse effect on stimulation or early pregnancy outcomes after IVF,' the New York City-based researchers at the Icahn School of Medicine at Mount Sinai and Mount Sinai West hospital wrote in the study. 'Our findings contribute to the growing body of evidence regarding the safety of COVID-19 vaccination in women who are trying to conceive.'
The HHS document also includes an incorrect link for that study, instead leading to a different study — also cited in HHS' document — by Israeli researchers that found the vaccine 'appears to be safe during pregnancy,' with no increase in preterm labor or in newborns with low birth weight.
That February 2022 study did note a possible increase in preterm birth rates for women vaccinated during the second trimester, and the authors suggested future investigations of outcomes based on the timing of immunization.
HHS' assertion about significant risks to pregnant women 'contradicts the bulk of published studies,' said Dr. Paul Offit, an expert who has served as an outside adviser on vaccines to the FDA and the CDC.
HHS deviated from past practice when it changed the Covid vaccine guidance last month, announcing the decision without the endorsement of an existing outside panel of expert advisers.
Dr. Steven Fleischman, president of the American College of Obstetricians and Gynecologists, told POLITICO at the time that he was disappointed by HHS' decision, and pointed to data showing that newborns can benefit from maternal antibodies from the vaccine for protection from Covid.
'In fact, growing evidence shows just how much vaccination during pregnancy protects the infant after birth, with the vast majority of hospitalized infants less than 6 months of age — those who are not yet eligible for vaccination — born to unvaccinated mothers,' Fleischman said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Epoch Times
2 minutes ago
- Epoch Times
HHS Rolls Out MAHA in Action to Spotlight Health Reforms
Early in his tenure as Secretary of Health and Human Services, Robert F. Kennedy Jr. vowed to make transparency a key element of the department under his leadership. This week, HHS announced the debut of MAHA in Action, an online platform highlighting federal initiatives and state-led reforms implementing the Make America Healthy Again (MAHA) agenda. MAHA in Action offers visibility into how health care reforms are working in communities across the country, according to a HHS press release.

USA Today
2 hours ago
- USA Today
Supreme Court allows Trump to cut $783 million in NIH research grants he targeted for DEI
The Trump administration targeted the National Institute of Health grants as part of its crackdown on diversity, equity and inclusion. WASHINGTON – The Trump administration can cancel $783 million in health research funding it says promotes diversity, equity and inclusion, the Supreme Court said Aug. 21 in its latest ruling that allows the president to move forward with policy changes being challenged in court. Chief Justice John Roberts and the court's three liberals said they would have kept the cuts on hold. The court kept on hold the government's guidance that it would not approve future funding related to DEI objectives, gender identity or COVID-19. But a majority agreed with the administration that the dispute over cuts to existing grants belonged in a different court. The high court's ruling comes after a federal judge in Massachusetts found that the administration's termination of National Institutes of Health grants was "breathtakingly arbitrary and capricious' and supported with 'sparse pseudo-reasoning.' U.S. District Judge William Young, who was appointed to the bench by Republican President Ronald Reagan, also said the grant cancellations represented 'racial discrimination and discrimination against America's LGBTQ community.' 'I've never seen a record where racial discrimination is so palpable,' Young said during a June hearing. DEI explained: What is DEI and why is it so divisive? What you need to know. But the Trump administration said the judge did not have the authority to weigh in. Lawyers for the administration argued that the challenges from researchers, the American Public Health Association and states led by Democrats must be brought in a different court that handles government contract disputes. The Justice Department lawyers said the Massachusetts judge should have known that, based on the Supreme Court's April order that permitted the Education Department to halt millions of dollars in teacher-training grants for the same reason. More: The trickle-down effect of President Trump's massive NIH budget cuts Even if the district court had jurisdiction, the grant terminations 'reflect quintessential policy judgments on hotly contested issues that should not be subject to judicial second-guessing,' Solicitor General John Sauer told the Supreme Court. "It is hardly irrational for agencies to recognize − as members of this Court have done − that paeans to 'diversity' often conceal invidious racial discrimination," he wrote. The American Public Health Association said this case differs from the cuts to teacher-training grants that the Supreme Court allowed to proceed. And allowing an "unprecedented disruption" to ongoing research into such matters as the cause of Alzheimer's, the drivers of heart disease in the rural South and the means for countering antibiotic resistance would cause "incalculable losses in public health," lawyers for the association told the Supreme Court. The NIH is the primary source of federal funding for biomedical research in the United States, and is the largestpublic funder of biomedical research in the world. The grants in this case represent a small portion of the research funding the Trump administration has terminated. In June, dozens of scientists, researchers and other NIH employees signed an open letter criticizing the agency's actions and spending cuts under President Donald Trump, which they said politicize research and "harm the health of Americans and people across the globe." Contributing: Reuters
Yahoo
3 hours ago
- Yahoo
‘Razor Blade' COVID-19 Variant Stratus Drives Up Cases In VA
The Stratus 'razor blade' variant is driving up COVID-19 cases in much of the country, according to new government estimates. In Virginia, case activity is growing, based on an estimate by the Centers for Disease Control and Prevention. The XFG variant was first detected in January in Southeast Asia, and the earliest U.S. case was in March. In mid-June, XFG comprised 14 cases nationwide, but the NB.1.8.1, or 'Nimbus' variant, remained the dominant strain. According to the Centers for Disease Control and Prevention's wastewater surveillance data, XFG is now the dominant variant circulating in the United States. The agency said COVID-19 cases are growing or likely growing in 34 states and remain unchanged in 14. Both the percentage of positive laboratory tests and the number of emergency department visits among people of all ages are increasing. Here's a snapshot of activity in Virginia as of Thursday, Aug. 21: COVID-19 emergency room visits: 1.3 percent of emergency room visits Viral activity in wastewater: Moderate The wastewater surveillance data was collected from 34 participating water utilities in Virginia. XFG causes a severe sore throat and hoarseness, hence the 'razor blade COVID' nickname. Symptoms common to other variants include fever or chills, cough, shortness of breath or difficulty breathing, sore throat, congestion and runny nose, loss of taste or smell, fatigue, muscle and body aches, headache, nausea and vomiting, and diarrhea. The variant may be better than others at evading immunity protection, according to experts. Although vaccine guidance is changing, the CDC website still says the COVID-19 vaccine helps protect against 'severe illness, hospitalization and death.' Related: 'Perfect Storm' For Infectious Diseases Brews As Kids Head Back To School What To Know About 'Razor Blade' COVID Variant Stratus Do I Need A Measles Booster: What Vaccinated Adults Need To Know 'Razor Blade' COVID-19 Variant Stratus Drives Up Cases In VA originally appeared on the Woodbridge Patch Play Farm Merge Valley